chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain on arm; rash on arm; hair loss in clumps; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient did not receive any medication within two weeks of vaccination. The patient did not have any allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced pain, rash on arm.  Days later hair loss in clumps was noticed as well on an unknown date in Apr2021. It was unknown whether therapeutic measures were taken as a result for the reported adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events pain, rash on arm and hair loss in clumps was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Case number PHEH2014US016878 is an initial spontaneous report received from a nurse on 20 Aug 2014. This report refers to 19 years old male patient. His medical history and concomitant medications were not reported. He received only Men C, Y, W-135 liquid conjugate component of MENVEO (batch number: not reported) without being reconstituted with Men A lyophilized conjugate component intramuscularly on 18 Aug 2014. No adverse event was reported following this administration error (inappropriate preparation of medication). Non-significant follow up report received from the nurse on 01 Oct 2014: Reporter did not want to fill the follow up form.
Patient presented with transverse myelitis with flaccid paralysis of BLE and a sensory level at T7.  Post PLEX and Steroids, patient has gotten very little motor function back (toe movement), and some sensation back
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 03-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.
Symptoms began 2/5 which initially started with high blood pressure. Dizziness, motion sickness, migraines, vertigo, impaired balance followed. Diagnosis was Vestibular neuritis related to inflammation from vaccine.
hot circle; red, hot circle; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (hot circle) and ERYTHEMA (red, hot circle) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HOT FLUSH (hot circle) and ERYTHEMA (red, hot circle). At the time of the report, HOT FLUSH (hot circle) and ERYTHEMA (red, hot circle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Left deltoid area tissue hard, red and hot to touch.  Symptoms reported to us by Mother.  Reaction area redness and swelling measuring 4 inches x 3 inches reported to us again by Mother.
High fever and flu-like symptoms for 4 days. Then 1.5 weeks later swelling in lower right leg, itching, redness (like a bad sunburn), tenderness to the touch, and pronounced pain when standing from a lying or sitting position. Symptoms got worse over 5 days, then subsided over 1-2 weeks. It took about a month for 95% of symptoms to go away, although there is still very minor residual pain months later.
Approx 2 weeks after booster administered I began to experience chronic thumb and wrist arthritis in left hand progressing to right hand and to date 3/11/22) it has not resolved. Reporting because my sister is coincidentally experiencing the same issue post Pfizer   covid vaccine.  Auto immune diseases do run in my family, however I have not previously experienced any arthritis to my hands until just after the 3rd shot.
A mother reported that her son received a third dose of Acel-Imune vaccine on 3/29/99, when he was six months old. Subsequently to immunization, he developed a high pitch scream and "high" fever. In the summer of 2002, he was diagnosed with autism. The child experienced daily fever, headache, constipation and has completely white hair with a piece of jet black hair scattered here and there. The mother thinks thimerosol in the vaccine is to blame for her son's condition. This case was considered serious since these events were considered medically important in this case. The mother reported that after her son received a 1st and 2nd dose of Acel-Imune, he develped a high pitch scream and "high" fever. See related cases HQ4066804SEP2002 and HQ4067004SEP2002. The mother also reported that a twin brother of the pt and a female sibling experienced similar events following immunizations. See related cases HQ4066704SEP2002, HQ3981728AUG2002, HQ4066504SEP2002 and HQ4066604SEP2002. No additional info was available as of the date of this report.
High fever, muscle aches, chills, headache, couldn't sleep, sore throat. One of the most intense 6 hours of my life. The symptoms started at 1.30am and lasted until 8am. Still feeling tired and beat up, it's like I got hit by a semi-truck.
sore arm after initial series; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after initial series) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm after initial series). At the time of the report, PAIN IN EXTREMITY (sore arm after initial series) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient concomitant medication included medication for sugar, medication for the heart, medication for cholesterol, medication for high blood pressure.  No treatment medications were reported.
Large red area at administration site. Heat and pain. Immunization administered 04Nov17 and was reported 06Nov17.
Rheumatoid Arthritis; Anemia; Kidney Disease; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP), Program ID. A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHEUMATOID ARTHRITIS (medically significant), outcome "unknown"; ANAEMIA (non-serious), outcome "unknown", described as "Anemia"; NEPHROPATHY (non-serious), outcome "unknown", described as "Kidney Disease". Clinical course: That she had watched that vaccine put her sister through and she hate it! It gave her Rheumatoid Arthritis; Anemia; Kidney Disease.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300092438 same reporter/drug, different pts/event;
pt called vaccine hotline saying since last week patient has had migraines every evening after work , lasting 2-3 hrs. Pt does not have a family hx  or personal hx of migraines. He is not taking medications and is drinking a lot of water. Pt is currently working in a remote area. Pt was concerned re ER costs and was reluctant to go but did say he would try. He was advised to go to the nearest ER. He then had to get off phone
Moderna COVID- 19 Vaccine EUA  Injection site pain lasted 24 hours, Fatigue, Muscle pain,Chills lasted 4 hours
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 10-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength: 0.5ml)(lot # L036245, expiration date 09-FEB-2018). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer)(R/F) for each time were 40, 34 and R; 136, 33 and R. The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 28-NOV-2018, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R001658 with expiration date 17-JAN-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
a little dehydrated; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (a little dehydrated) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEHYDRATION (a little dehydrated). At the time of the report, DEHYDRATION (a little dehydrated) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Patient did not receive any treatment.   This case was linked to MOD-2021-365126 (Patient Link).
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with VAQTA (dose, route of administration, lot # and expiry date were not reported) that were improperly stored. No adverse symptom was reported. It was reported that the temperature excursion was unsupported with in-house stability data. This is one of several reports received from the same reporter. Additional information has been requested.
p/vax pt exp a rash w/8-15 lesions on the face;no fever or any other sx reported;
dizziness; Shingles; my arms feeling like there's needlesticks.; high blood pressure; vertigo; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (my arms feeling like there's needlesticks.), HYPERTENSION (high blood pressure) and VERTIGO (vertigo) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 034A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (my arms feeling like there's needlesticks.), HYPERTENSION (high blood pressure), VERTIGO (vertigo) and PYREXIA (Fever). At the time of the report, DIZZINESS (dizziness), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (my arms feeling like there's needlesticks.), HYPERTENSION (high blood pressure), VERTIGO (vertigo) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.9 f (High) 102.9 F.         Concomitants were not provided. Treatment was not provided.
The patient thinks that the pharmacist hit a nerve/It hurt at soon he put the needle in /Her arm was very painfull and swollen/She felt it went too deep; The patient thinks that the pharmacist hit a nerve/It hurt at soon he put the needle in /Her arm was very painfull and swollen/She felt it went too deep; The patient thinks that the pharmacist hit a nerve/It hurt at soon he put the needle in /Her arm was very painfull and swollen/She felt it went too deep; The patient thinks that the pharmacist hit a nerve/It hurt at soon he put the needle in /Her arm was very painfull and swollen/She felt it went too deep; This spontaneous report was received from a female consumer of unknown age, via Pfizer, referring to herself. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On an unknown date, the patient was vaccinated with the first dose of Zoster Vaccine Live (manufacturer unknown) (also reported as "shingles vaccine") as prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location, lot number, and expiration date were not reported).   On an unknown date, the patient was vaccinated with the second dose of Zoster Vaccine Live (manufacturer unknown) (also reported as "shingles vaccine") as prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location, lot number, and expiration date were not reported).   On an unknown date after the second dose, the patient reported that she believed the pharmacist hit a nerve because it hurt as soon as he put the needle in, and it caused her arm to be very painful and swollen. She also reported that she felt the needle went too deep and hit a nerve, and when the needle went in, it felt very different on this second dose than from the first dose (vaccination site nerve damage, vaccination site pain, vaccination site swelling, wrong technique in product usage process).   The outcome of the aforementioned events was unknown, and the causal relationship between the events and vaccination with Zoster Vaccine Live (manufacturer unknown) were not provided.
weakness, fall Narrative:  Pt with history of CAD (s/p PCI mid and prox RCA in 2006, on ASA/Plavix; CABG, AVR), afib, GERD, HTN, HLD, hypothyroidism, BPH, diverticulosis, aortic stenosis, small fiber neuropathy (since 2010), lumbar stenosis at S1. Also, pt presented to outside ED on 12/26/20 for increasing falls and weakness over one week and was admitted to outside hospital 12/26/20 for generalized weakness, dehydration, hyponatremia all secondary to covid 10 infection. Hospital course included sepsis due to covid 19, elevated liver enzymes, acute kidney injury. Pt discharged 12/29/2021. After first COVID vaccine 2/12/2021, patient experienced fever x 1 day, weakness, and fall. Presented to outside ED 2/13/21 abd was admitted for critical illness myopathy 2/2 recent COVID infection +/-COVID vaccination. Pt was discharged 2/18/2021.
Patient states she had an approx 3 in circle that was red and warm to the touch the day after she got the shot. The spot is now approx 1 in in dia. Her right arm is swollen 1/2 inch greater than her left (circumf). She states it gave her a fever, but she was not able to take her temp because she doesn't have a thermometer. She has also noticed swelling in her ankles and around her eyes.
UC given a 2nd dose of Pfizer Covid Vaccine on 2/22/2022. The Nurse didn't realize an initial dose was given on 2/13/2022, Which made the 2nd too soon to be given. UC was monitored with no adverse affects noted. CMO notified and made aware.
Diffuse, small pustules on trunk/chest; disseminated vaccinia; mild itching.
Pt recvd series of Engerix-B vax on 17JAN91, 14FEB91, & 13MAR91; Recvd HIG w/1st dose of vax; Pt recvd vax series during second trimester of pregnancy; Baby was born prematurely w/hyaline membrane dis, & asthma;
Intense waves of nausea; Fatigue; Phantom smells; This is a spontaneous report from a non-contactable consumer or other non-hcp (Patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 34-year) on 29Jan2021 as dose 1, single for COVID-19 immunization. Medical history was reported none. The patient's concomitant medications were not reported. Facility type vaccine was Workplace clinic as reported. No known allergies were reported. The patient had no other vaccine in four weeks. The patient had no other medications in two weeks. No COVID prior vaccination was reported. The patient not tested COVID post vaccination. On 30Jan2021 the patient experienced intense waves of nausea, fatigue, phantom smells. The patient was received no treatment for the adverse events. The clinical outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
patient had received same vaccine on 09/29/22 and was not due for vaccine. Dose given on 1/21/23 was unnecessary.
Suspected vaccination failure/Both Shingrex in 2018. Shingles 5 times since; have had shingles 5 times since then/Got them after a surgery or during rehabbing; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 61-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant and other) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 15-Dec-2022 Reporter's comment: The patient had received both the injections of Shingrix  in 2018 and have had the shingles 5 times since then. The patient got them after a surgery or during rehabbing after surgery. The patient asked that he/she should get another vaccine and booster or any other advice. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
While seated waiting the recommended 15 minutes,  At around the 10 min mark, I began feeling increasing tingling in right arm, then sweating profusely, then vision became vertigo-like. I slowly stood up to walk away and try to step outside to catch some air, but soon after had syncope (first episode in my life though I?ve had vertigo-like symptoms after donating blood, reason for which I?ve always remained lying down for at least an hour after donating). I woke up to bystander who apparently assisted me during the fall (fortunately no injuries resulted). Pharmacy employee showed up and began to assist bystander. I brought myself to a sitting position by they asked me to try and stand up to walk back to vaccination room. As I entered that room I again had another syncope episode. Regained consciousness with bystander and employee assisting me off the floor and on to a chair. Employee informed me that I shook briefly while on the floor. I began to feel better but still unstable. A friend picked me up and took me to the ER, where an EKG was performed. Vitals were normal but minor sinus bradycardia diagnosed. I am athletic with BMI under 25 so resting BPM has been 57-60 for at least few years per fitness watch.   I have no allergies or fear of needles.
Patient given PENTACEL in right upper thigh - within 24 hours he was unable to use his leg to stand or crawl for 7 days - given an absence of any other symptoms except local pain and lameness no treatment was Rx. Recovery complete after 7 days.